Related Experiment Video
Updated: Jun 10, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Reduction in spasm with a long hydrophylic transradial sheath
Christophe Caussin1, Mostari Gharbi, Chloé Durier
1Hôpital Marie Lannelongue, Le Plessis Robinson, France. c.caussin@ccml.fr
Insights
A long hydrophilic sheath significantly reduces radial artery spasm during transradial procedures compared to a short sheath. This innovation improves patient comfort and procedural success in cardiac catheterization.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Access
Background:
- Transradial approach offers lower access site complications but is underutilized.
- Radial artery spasm is a significant challenge in transradial procedures.
- A long hydrophilic-coated sheath may mitigate radial spasm compared to standard sheaths.
Purpose of the Study:
- To evaluate the efficacy of a long hydrophilic-coated sheath in preventing radial artery spasm during transradial approach.
- To compare the incidence of radial spasm between long hydrophilic-coated and short sheaths.
Main Methods:
- A randomized controlled trial involving 351 patients undergoing transradial coronary angiography ± PCI.
- Patients were assigned to either a long hydrophilic-coated sheath or a short sheath (control).
- Radial spasm was the primary endpoint, defined by patient pain scores or catheter friction; procedure failure, occlusion, and local complications were secondary endpoints.
Main Results:
- Radial spasm occurred significantly less frequently with the long hydrophilic-coated sheath (4%) versus the short sheath (18%) (P < 0.001).
- No significant differences were observed in procedure failure rates (1.2% vs. 0.6%), local complications (0.6% vs. 1.2%), or radial occlusion (3.5% vs. 3.5%).
Conclusions:
- The long hydrophilic-coated sheath is effective in preventing radial artery spasm during transradial procedures.
- This sheath offers a promising solution to improve the adoption and success of the transradial approach.
Objectives:
We aimed to assess the efficiency of a long hydrophilic sheath in reducing radial spasm for transradial approach.
Background:
Despite a lower access site complication rate, cardiac catheterization using transradial approach is not widely used. Radial spasm is one of the main issues for transradial angiography and percutaneous interventions. We assumed that radial artery protection using a long hydrophilic-coated sheath would reduce radial spasm compared to a bare short sheath.
Methods:
Three hundred and fifty one patients (pts) admitted for transradial coronary angiography ± percutaneous coronary interventions were randomly assigned to a long hydrophilic-coated or a short sheath (control group). Primary end point was the occurrence of a radial spasm defined by significant patient pain evaluated by scale score (>4) or significant catheter frictions during manipulation. Procedure failure, radial occlusion, and local complications were also assessed.
Results:
Radial spasm was significantly reduced when using the long-coated compared to the short sheath in 7 (4%) vs. 32 pts (18%) P < 0.001. No difference was found regarding procedure failure respectively 1.2% vs. 0.6%, local complication 0.6% vs. 1.2%, and radial occlusion 3.5% vs. 3.5%.
Conclusion:
Radial artery protection using the long hydrophilic-coated sheath was efficient in the prevention of radial spasm for transradial approach. © 2010 Wiley-Liss, Inc.
Related Concept Videos
Vascular Spasm
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripheral Artery Disease III: Interprofessional Care
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
